EMA Authorised: Xenical (orlistat) — CHEPLAPHARM Arzneimittel GmbH

View source ↗

Summary

European Medicines Agency authorises Xenical (orlistat) for obesity through CHEPLAPHARM Arzneimittel GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• XENICAL (orlistat)

Snippet

Status: Authorised. Therapeutic area: Obesity. MAH: CHEPLAPHARM Arzneimittel GmbH. Decision date: 10/05/2023